NCT01280305 Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder Status UNKNOWN Phase PHASE3
NCT01279213 Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia Status COMPLETED Phase PHASE4
NCT01269710 Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study Status COMPLETED Phase N/A
NCT01268124 Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects Status COMPLETED Phase PHASE1
NCT01266174 Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults Status COMPLETED Phase PHASE2
NCT01263080 Evaluation of Mirtazapine and Folic Acid for Schizophrenia: Status COMPLETED Phase PHASE4
NCT01259427 Reducing Internalized Stigma in People With Serious Mental Illness Status COMPLETED Phase PHASE2
NCT01258920 A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01250847 Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) Status UNKNOWN Phase PHASE4
NCT01249079 Expanding Rapid Ascertainment Network of Schizophrenia Families in Taiwan Status UNKNOWN Phase N/A
NCT01248195 Optimization of Treatment and Management of Schizophrenia in Europe Status COMPLETED Phase PHASE4
NCT01246232 Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia Status COMPLETED Phase PHASE4
NCT01246128 Nicotinic Receptor Density in Smoking and Nonsmoking Schizophrenics Status WITHDRAWN Phase N/A
NCT01244854 Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental Illness Status COMPLETED Phase NA
NCT01244828 Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238) Status COMPLETED Phase PHASE3